109 related articles for article (PubMed ID: 24196629)
21. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.
Llosa NJ; Cruise M; Tam A; Wicks EC; Hechenbleikner EM; Taube JM; Blosser RL; Fan H; Wang H; Luber BS; Zhang M; Papadopoulos N; Kinzler KW; Vogelstein B; Sears CL; Anders RA; Pardoll DM; Housseau F
Cancer Discov; 2015 Jan; 5(1):43-51. PubMed ID: 25358689
[TBL] [Abstract][Full Text] [Related]
22. Molecular biology of colorectal cancer.
Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
[TBL] [Abstract][Full Text] [Related]
23. Clonal origins and parallel evolution of regionally synchronous colorectal adenoma and carcinoma.
Kim TM; An CH; Rhee JK; Jung SH; Lee SH; Baek IP; Kim MS; Lee SH; Chung YJ
Oncotarget; 2015 Sep; 6(29):27725-35. PubMed ID: 26336987
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical expression pattern of MMR protein can specifically identify patients with colorectal cancer microsatellite instability.
Amira AT; Mouna T; Ahlem B; Raoudha A; Majid BH; Amel H; Rachida Z; Nadia K
Tumour Biol; 2014 Jul; 35(7):6283-91. PubMed ID: 24643686
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite instability in colorectal cancer.
Boland CR; Goel A
Gastroenterology; 2010 Jun; 138(6):2073-2087.e3. PubMed ID: 20420947
[TBL] [Abstract][Full Text] [Related]
26. [Pathogenesis of microsatellite-unstable colorectal cancer. Evaluation of new diagnostic and therapeutic options].
Kloor M
Pathologe; 2013 Nov; 34 Suppl 2():277-81. PubMed ID: 24196629
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of microsatellite instability in colorectal cancer.
Kloor M; Staffa L; Ahadova A; von Knebel Doeberitz M
Langenbecks Arch Surg; 2014 Jan; 399(1):23-31. PubMed ID: 24048684
[TBL] [Abstract][Full Text] [Related]
28. Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome.
Reuschenbach M; Kloor M; Morak M; Wentzensen N; Germann A; Garbe Y; Tariverdian M; Findeisen P; Neumaier M; Holinski-Feder E; von Knebel Doeberitz M
Fam Cancer; 2010 Jun; 9(2):173-9. PubMed ID: 19957108
[TBL] [Abstract][Full Text] [Related]
29. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.
Schwitalle Y; Kloor M; Eiermann S; Linnebacher M; Kienle P; Knaebel HP; Tariverdian M; Benner A; von Knebel Doeberitz M
Gastroenterology; 2008 Apr; 134(4):988-97. PubMed ID: 18395080
[TBL] [Abstract][Full Text] [Related]
30. Lynch syndrome-associated colorectal carcinoma: frequent involvement of the left colon and rectum and late-onset presentation supports a universal screening approach.
Hartman DJ; Brand RE; Hu H; Bahary N; Dudley B; Chiosea SI; Nikiforova MN; Pai RK
Hum Pathol; 2013 Nov; 44(11):2518-28. PubMed ID: 24034859
[TBL] [Abstract][Full Text] [Related]
31. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
32. Endometrial and ovarian cancer in women with Lynch syndrome: update in screening and prevention.
Lu KH; Daniels M
Fam Cancer; 2013 Jun; 12(2):273-7. PubMed ID: 23765559
[TBL] [Abstract][Full Text] [Related]
33. Towards a vaccine to prevent cancer in Lynch syndrome patients.
von Knebel Doeberitz M; Kloor M
Fam Cancer; 2013 Jun; 12(2):307-12. PubMed ID: 23760517
[TBL] [Abstract][Full Text] [Related]
34. Identification and selective degradation of neopeptide-containing truncated mutant proteins in the tumors with high microsatellite instability.
Kim WK; Park M; Park M; Kim YJ; Shin N; Kim HK; You KT; Kim H
Clin Cancer Res; 2013 Jul; 19(13):3369-82. PubMed ID: 23674496
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status.
Koelzer VH; Baker K; Kassahn D; Baumhoer D; Zlobec I
J Clin Pathol; 2012 Nov; 65(11):996-1002. PubMed ID: 22859396
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]